Advanced search

Main

Company reports

Hemosol Corp - Financial Report

Publications

Business, Finance & Insurance (35706)

Consumer Goods & Retail (127031)

Databases & Statistics (27)

Education & Consulting (0)

Industry (87698)

Healthcare, Pharmaceuticals & Biotechnology (58540)

Services (0)

Government and Public Sector (553)

Technologies & Electronics (91477)

Company reports (70860)

Country reports (2187)

(Currently 512486 Items)

Partners

Company reports / REPORT INFORMATION

Hemosol Corp - Financial Report
Date	Oct, 2006
Pages	11
Price / format	$350 / Online Download $700 / Global Site License

$350

Report Information | Custom-Tailored Research | Product Trade Lead

Abstract:
The Hemosol Corp Financial Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues. The report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally the report includes quarterly book value per share vs. share price. Much of the information contained in the report is included in both tabular and graphic formats.

Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline and financial information on more than 8,000 biomedical companies worldwide. Our data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes.

Life Science Analytics reports are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. LSA distills and systematizes pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide it’s clients with the most comprehensive and up-to-date information available. The Hemosol Corp Financial Report therefore delivers the latest and the most comprehensive intelligence available on Hemosol Corp's financial performance.

Table of contents:

Company Details: Price Info (Table/Graph)
Business Overview: Share Price Information; Stock Performance History(Last 3 Yrs) (Graph)
Price and Volume: Dividends (Table/Graph); Market Related Data (Table/Graph); Valuation (Table/Graph); Revenues (Table/Graph)
Earnings and Earnings Per Share: Margin Ratios (Table/Graph); Return Ratios (Table/Graph); Financial Strength (Table/Graph)
Growth Ratios: Days Sales Outstanding (End of Period Receivables); Days Outstanding Inventory (End of Period Inventory); Cash and Short Term Investments per Share - Quarterly (Graph); Total Common Shares Outstanding - Quarterly (Graph); Quarterly Book Value Per Share vs Share Price (Graph)

Order this report

Product Trade Lead

0 leads found

Add New Buy/Sell Lead